The Scientific Committee of the Fondation Jérôme Lejeune is composed of 23 independent experts who help us in the evaluation and selection of the research projects submitted through our calls
Jean-Louis Guéant, MD, Ph.D, PU-PH, Research Director INSERM
President of the Scientific Committee of the Fondation Jérôme Lejeune Nutrition, Génétique et Exposition aux risques Environnementaux (NGERE), Université de Lorraine, Vandoeuvre-les-Nancy, France
Yann Hérault, Ph.D, Research Director CNRS
Honorary chair Scientific Committee of the Fondation Jérôme Lejeune
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg & Institut Clinique de la Souris (ICS) Illkirch, France
Marie-Claude Potier, PharmD, Ph.D, Research Director CNRS
Honorary chair Scientific Committee of the Fondation Jérôme Lejeune
Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpêtrière, Paris, France
Paul Bastard, MD, Ph.D
Institut Imagine (Université de Paris, INSERM, AP-HP), Paris, France
Eugenio Barone, Prof., Ph.D
Sapienza University of Rome, Faculty of Medicine, Roma, Italy
Jacques S. Beckmann, Prof., Ph.D
Honorary Professor Université de Lausanne (UNIL), Lausanne, Switzerland
Cécile Cieuta-Walti, MD
Institut Jérôme Lejeune, Paris, France
University of Sherbrooke, Québec, Canada
Aurore Curie, MD, Ph.D, MCU-PH
Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Institut des Sciences Cognitives Marc Jeannerod, Bron, France
Alain D. Dekker, Ph.D
Head of the department of practice-oriented scientific research of Alliade Care Group, Beetsterzwaag, & University Medical Center Groningen, The Netherlands
Juan Fortea Ormaechea, MD, Ph.D
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Mario Gomes-Pereira, Ph.D, Research Director DR2 INSERM
Institut de Myologie, Sorbonne Université, Paris, France
Faycal Guedj, Ph.D
National Institutes of Health (NIH), Bethesda, Maryland, United States
Julien Laffaire, Ph.D
Biostatistics manager, Pharnext, Paris, France
Fréderic Laumonnier, Ph.D, Research Director INSERM
Faculté de Médicine, Université de Tours, France
Thomas Lecuit, Prof., Ph.D
Institut de Biologie du Développement de Marseille (IBDM), France, & Collège de France, Paris
Patrícia Maciel, Ph.D
University of Minho, School of Medicine, Porto, Portugal
Silvia de Marchis, Ph.D
University of Turin, Life Sciences and Systems Biology, Torino, Italy
Eimear McGlinchey, Ph.D, Assistant Professor in Intellectual Disability in the School of Nursing & Midwifery
Trinity Centre for Ageing and Intellectual Disability, Trinity College Dublin, Ireland
Massimo Mantegazza, Ph.D, Research Director DR2 INSERM
Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France
Andre Mégarbané, MD, Ph.D
Institut Jérôme Lejeune, CRB BioJeL, Paris, France
Clotilde Mircher, MD
Institut Jérôme Lejeune, Paris, France
Hervé Moine, Ph.D, Research Director CNRS
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
Juan Narbona Garcia, MD
Clinica Universitária de Navarra, Pamplona, Spain
Andrés Ozaita, Prof., Ph.D
University of Pompeu Fabra, Department of Medicine and Life Sciences, Barcelona, Spain
Florence Rage, Ph.D, DR2 CNRS, Research in Molecular Biology
Institut de Génétique Moléculaire, Montpellier, France
Daniel Satgé, MD
ONCODEFI and Institut Universitaire de Recherche Clinique, Montpellier, France
Margarida Saraiva, Ph.D, Group leader, Immune Regulation
I3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal
Frances Wiseman, Ph.D
University of College London (UCL), Group Leader and Programme Leader for Animal Models, London, United Kingdom
Binnaz Yalçin, Ph.D, Dr Inserm
Institut NeuroMyoGène, Université de Lyon, Claude Bernard Lyon 1, France
2026.08.20